RESUMEN
BACKGROUND: Human herpesvirus-6 (HHV-6) is known to reactivate after renal transplantation and has been associated with several clinical manifestations. Risk factors for sustained viral replication, however, remain unclear. METHODS: Thirty consecutive kidney transplant patients were prospectively followed for HHV-6 replication between February 2007 and February 2008. Plasma samples for DNA detection were collected from the donor and the recipient before transplantation and from the recipient weekly for the first 2 months after transplantation and then every 2 weeks for 2 additional months. HHV-6 active infection was defined as detection of viral DNA in plasma, by polymerase chain reaction, in at least two consecutive samples over an interval of at least 1 week. RESULTS: Active viral infection was detected in 25% of the recipients before transplantation and 27% (8 of 30) of the patients after transplantation. The mean time to onset of viral replication was 28.1 days after transplantation and 7 of 8 (87.5%) were asymptomatic. Risk factors associated with active HHV-6 infection were receiving an organ from a living donor (P=0.028), recipients with IgM antibodies detected before transplantation (P=0.005), and pretransplantation recipient HHV-6 viral load more than 10,000 copies/mL plasma (P=0.034). CONCLUSIONS: Active HHV-6 infection occurs early after renal transplantation and is mostly asymptomatic. Donor or recipient infection may occur at the time of transplantation and are related to higher rates of posttransplantation infections.
Asunto(s)
Infecciones por Herpesviridae/complicaciones , Infecciones por Herpesviridae/diagnóstico , Herpesvirus Humano 6/metabolismo , Trasplante de Riñón/efectos adversos , Insuficiencia Renal/complicaciones , Insuficiencia Renal/terapia , Adolescente , Adulto , Anciano , ADN Viral/metabolismo , Femenino , Supervivencia de Injerto , Humanos , Trasplante de Riñón/métodos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa/métodos , Estudios Prospectivos , Factores de Riesgo , Resultado del Tratamiento , Replicación ViralRESUMEN
A group of 208 human immunodeficiency virus (HIV)-infected women in Brazil were studied for the presence of human papillomavirus with the general SPF(10) PCR primer set. Virtually all (98%) women were found positive for human papillomavirus (HPV) DNA. Genotyping by the reverse hybridization line probe assay (HPV-LiPA) revealed a high prevalence of multiple genotypes (78.9% of the cases), with an average of 3.1 genotypes per patient (range, 1 to 10 genotypes). HPV 6 was the most prevalent genotype and was observed in 80 (39.2%) patients, followed by types 51 (31.9%), 11 (26.0%), 18 (24.0%), and 16 (22.5%). Of the genotypes detected, 40.9% were low-risk genotypes. Twenty-two (10.5%) patients showed normal (Pap I) cytology, 149 (71.6%) patients had inflammation (Pap II), and 28 patients (13.4%) had a Pap III score. The prevalence of high-risk genotypes increased with the cytological classification. There were no significant associations between the number of HPV genotypes detected and the cytological classification, HIV viral load, and CD4 count in these patients. In conclusion, the highly sensitive SPF(10) LiPA system shows that a very high proportion of HIV-infected women in Brazil are infected with HPV and often carry multiple HPV genotypes.
Asunto(s)
Infecciones por VIH/complicaciones , Infecciones por VIH/epidemiología , Papillomaviridae/clasificación , Infecciones por Papillomavirus/epidemiología , Infecciones Tumorales por Virus/epidemiología , Brasil/epidemiología , ADN Viral/análisis , Femenino , Genotipo , VIH-1/aislamiento & purificación , VIH-1/fisiología , Humanos , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Reacción en Cadena de la Polimerasa , Prevalencia , Infecciones Tumorales por Virus/virología , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/virología , Displasia del Cuello del Útero/epidemiología , Displasia del Cuello del Útero/virologíaRESUMEN
HIV-infected women from S o Paulo city were enrolled in a cross-sectional study on Human Papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN) prevalence and their association with laboratory markers of AIDS, namely HIV viral load and CD(4)(+) cell counts. A cervical specimen was collected and submitted to Hybrid Capture, a test for HPV viral load determination. HPV-DNA was detected in 173 of 265 women (64.5%). Twenty (7.5%) women were infected by one or more low-risk viruses, 89 (33%) by one or more high-risk viruses, and 64 (24%) harbored at least one HPV type from each risk group. Abnormal smears were observed in 19% of the patients, though there were no invasive carcinomas. Severely immunosuppressed patients (CD(4)/microL <100) were at the greatest risk of having a cytological abnormality and a high high-risk HPV viral load.
Asunto(s)
Infecciones por VIH/complicaciones , Infecciones por VIH/virología , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/virología , Infecciones Tumorales por Virus/complicaciones , Neoplasias del Cuello Uterino/complicaciones , Carga Viral , Adolescente , Adulto , Factores de Edad , Anciano , Brasil/epidemiología , Recuento de Linfocito CD4 , ADN Viral/análisis , Femenino , VIH/aislamiento & purificación , Humanos , Persona de Mediana Edad , Neoplasias de Células Escamosas/complicaciones , Neoplasias de Células Escamosas/epidemiología , Neoplasias de Células Escamosas/virología , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/epidemiología , Prevalencia , Factores de Riesgo , Infecciones Tumorales por Virus/epidemiología , Infecciones Tumorales por Virus/virología , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/virología , Frotis VaginalRESUMEN
HIV-infected women from S o Paulo city were enrolled in a cross-sectional study on Human Papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN) prevalence and their association with laboratory markers of AIDS, namely HIV viral load and CD(4)(+) cell counts. A cervical specimen was collected and submitted to Hybrid Capture, a test for HPV viral load determination. HPV-DNA was detected in 173 of 265 women (64.5). Twenty (7.5) women were infected by one or more low-risk viruses, 89 (33) by one or more high-risk viruses, and 64 (24) harbored at least one HPV type from each risk group. Abnormal smears were observed in 19 of the patients, though there were no invasive carcinomas. Severely immunosuppressed patients (CD(4)/microL <100) were at the greatest risk of having a cytological abnormality and a high high-risk HPV viral load.
Asunto(s)
Humanos , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Neoplasias del Cuello Uterino , Carga Viral , Infecciones por VIH/complicaciones , Infecciones por VIH/virología , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/virología , Infecciones Tumorales por Virus/complicaciones , Papillomaviridae , Brasil , ADN Viral , Neoplasias del Cuello Uterino , Prevalencia , Factores de Riesgo , VIH , Frotis Vaginal , Factores de Edad , Infecciones por Papillomavirus/epidemiología , Infecciones Tumorales por Virus/epidemiología , Infecciones Tumorales por Virus/virología , Neoplasias de Células Escamosas/complicaciones , Neoplasias de Células Escamosas/epidemiología , Neoplasias de Células Escamosas/virologíaRESUMEN
A 400mg dose twice-a-day oral acyclovir prophylaxis regimen was evaluated in 50 allogenic transplant recipients. Twenty (40 percent) patients experienced 24 episodes of herpes simplex virus (HSV) shedding; 17 (70.8 percent) occurring during prophylaxis. Thirteen of such episodes were asymptomatic and, in three, it was difficult to differentiate severe mucositis from viral lesions. In the remaining one, HSV pneumonia was suspected after a bronchoalveolar lavage (BAL) procedure performed in an attempt to early detection of cytomegalovirus (CMV). All cases responded to acyclovir therapy or dose adjustment suggesting that acyclovir resistance did not account for the occurrence of infection in our patients. These data demonstrated that oral acyclovir prophylaxis, 400mg dose twice-a-day, was inadequate to suppress viral shedding. The bronchoalveolar lavage procedure in a patient with HSV shedding could precipitate HSV spread to the lungs and the occurrence of pneumonia.